Management 2011 GROUP MEMBERS NAMES: M.NOUMAN MALIK (3892) SUNDAS (4800) WAQAS KHALID (3872) M.FAHAD ASLAM (3861) M.SAAD YOUSUF (3889) DATE OF SUBMISSION: 16-05-2011 1 Report Of Management 2011 Term Report: Management strategies of Sanofi Aventis Appointment: Furqan Hussain (HR Manager South) Appointment Date: 04-05-2011 Report Submitted to: Mr. Sanatullah (Department of BBA (H) Of Iqra University. Name of Students: M.NOUMAN MALIK (3892) SUNDAS (4800) WAQAS KHALID (3872) M.FAHAD ASLAM
Premium Management Pharmaceutical industry
“ Sanofi-Aventis‚ between innovation and acquisition” Wafi Djebbar Table of Contents Executive Summary 3 1. Introduction 3 2.Sanofi Description and Background......…………………………………………………………………………………….......4 3. Sanofi Business Environment 4 3.1. Political Factors 4 3.2. Economic Factors 5 3.3. Social Factors 7 3.4. Technological Factors 7 3.5. Environmental Factors 8 3.6. Legal Factors……………………………………………………………………………………………………………………………8 4. SWOT ANALYSIS……………………………………………………………………………………………………………………………9
Premium Pharmaceutical industry
Submitted To: Sir Abdul Qadir Molvi Submitted By: Mehmood Shekhani Contents objectives 4 INtroduction to sanofi Sanofi pakistan 5 Vision STATEMNT 6 Mission STATEMENT 6 ANALYSIS OF THE INDUSTRY USING MICHAEL PORTER’S FIVE COMPETITIVE FORCES 13 External Factor Evaluation 19 Competitive Profile Matrix (C.P.M) 21 Financial Trends 22 Interpretation 26 Value Chain Analysis 29 Support activities 32 Core Competencies 34 Strategic Cost Management Process 36 Internal Factor Evaluation
Premium Pharmaceutical industry Strategic management
the global sales. 40% of the total industry revenues took place in Europe and Japan. With regards to the market share ranking of the pharmaceutical sector by revenues‚ the leader in 2003 was Pfizer‚ GlaxoSmithKline‚ Merck‚ Johnson & Johnson and Aventis. However‚ due to patent expirations and new successful drug launches‚ the ranking of top pharmaceutical companies constantly faces numerous variations. The most sold drug in 2003 was Lipitor manufactured by Pfizer‚ with a global market share of 2
Premium Pharmaceutical industry
Term Project Introduction: | Sanofi-Aventis U.S.‚ based in Bridgewater‚ NJ‚ and employing 15‚000 people across the country‚ is part of a leading global pharmaceutical company that discovers‚ develops‚ and produces markets innovative therapies that enhance people’s lives. Their extensive research and development efforts are focused on health care challenges in cardiology‚ oncology and internal medicine‚ as well as metabolic diseases‚ central nervous system disorders and vaccines. LANTUS
Premium Medicine Pharmaceutical drug Health care provider
Performance Indicators / Pharmaceutical Plants: 41 C. Supply Chain Key Performance Indicators / Chemistry Plants: 42 D. Objectives of Performance 43 Conclusion 45 1 2 Introduction This report focuses on the suplly chain management of “Sanofi-Aventis” in Bangladesh‚ a leading global pharmaceutical company that discovers‚ develops and distributes therapeutic solutions to improve the lives of everyone. Present in more than 100 countries‚ with around 11‚000 scientists there are around 100‚000
Premium Supply chain management
http://www.bignerds.com/papers/11308/Strategic-Management/ Strategic Management View Full Essay Strategic Management Project Report Company: Sanofi-Aventis Pakistan Limited Executive Summary Sanofi-Aventis Pakistan Limited is one of the leading pharmaceuticals company in Pakistan. It focuses its activities on seven major therapeutic areas: cardiovascular‚ thrombosis‚ oncology‚ central nervous system‚ metabolic disorders‚ internal medicine and vaccines. Its portfolio of marketed products
Premium
Management on Domestic and Global Competition In Pakistan‚ Sanofi-Aventis and GlaxoSmithKline are pharmaceutical companies that market popular products and carry very similar medications. Companies like these have the mission and responsibility of providing medicines and vaccinations to better people’s live in different countries and communities. One of the largest and leading pharmaceutical companies in Pakistan is the Sanofi-Aventis Pakistan Limited. The chains put most of their focus on therapeutic
Premium Pharmaceutical industry Pharmacology
Summary Sanofi is the largest global pharmaceutical company in Bangladesh with a dedicated team of more than 1200 employees. Sanofi Bangladesh Limited is the entity that has been formed due to the amalgamation of three legal entities- Aventis Limited‚ Fisons (Bangladesh) Limited and Hoechst Marion Roussel Limited. The legal integration process has taken few years after the global merger between sanofi-synthalebo and Aventis in 15 September 2004 and finally the existing three legal entities
Premium
SANOFI Wake Up statement Sanofi is an integrated‚ global healthcare leader‚ which offers pharmaceutical drugs around the globe. Over the years‚ Sanofi has felt the pressure of patent cliffs‚ allowing generics to enter the market with comparable drugs at a fraction of the price. This is expected to have a negative impact on revenue and earnings‚ leading management to alter its strategy through diversification. After examining Sanofi’s current position and the pharmaceutical landscape
Premium Revenue Pharmaceutical industry Pharmacology